Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discounts will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
The drug-services firm Catalent is buying MaSTherCell, a cell therapy manufacturing specialist based in Gosselies, Belgium, for $315 million. MaSTherCell operates a clinical-scale facility in Gosselies. A commercial-scale plant under construction will more than double the site’s staff of 240. MaSTherCell is also building a facility in Houston that will employ about 50 when it opens later this year. Catalent entered the adjacent gene therapy service market last year with its $1.2 billion acquisition of Paragon Bioservices.
This article has been sent to the following recipient: